TrialReach Raises $1.2M in Funding

TrialReach, a London, UK-based website that helps patients with any medical condition to explore, understand and access the latest clinical trials, anywhere in the world, has raised $1.2m in funding.

The round was led by UK technology investor Amadeus Capital Partners Ltd.

The company intends to use the funds to further develop its platform with the addition of new tools and content for patients and clinical trial sponsors, and expand the services to other languages and territories around the world.

Co-founded by CEO Pablo Graiver and CMO Jessica Mann, MD, PhD, TrialReach is a global search and referral engine for clinical trials designed to make clinical trials easy to find out about, understand, and get access to. The company works with investigators and clinical trial sponsors, including global pharmaceutical companies, biotech companies and clinical recruitment organisations (CROs), to create online multimedia descriptions of the studies, as well as their accompanying user-friendly pre-screening questionnaires. The solution also includes a feature that gives patients the option to forward their own questions to healthcare professionals, usually the actual investigators of each study.



Join the discussion